Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease – a secondary analysis of the randomized TWENTE trials

Background: The presence of polyvascular atherosclerotic disease is associated with a high-risk of adverse events following percutaneous coronary intervention (PCI). As the extent to which the presence of diabetes further increases this elevated risk is unclear, based on current literature, we sough...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Daphne van Vliet, Tineke H. Pinxterhuis, Eline H. Ploumen, Marlies M. Kok, Rosaly A. Buiten, Paolo Zocca, Ariel Roguin, Carl E. Schotborgh, Rutger L. Anthonio, Peter W. Danse, Edouard Benit, Adel Aminian, Carine J.M. Doggen, Clemens von Birgelen
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2025-08-01
Rangatū:	International Journal of Cardiology: Heart & Vasculature
Ngā marau:	Coronary artery disease Peripheral arterial disease Polyvascular disease Diabetes mellitus Percutaneous coronary intervention
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2352906725001447
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!